This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Seoul National University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Zee-Won Lee: Innovator in Vibrio Infection Treatment
Introduction
Zee-Won Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of vibrio infections. His innovative approach focuses on developing alternatives to traditional antibiotics.
Latest Patents
Zee-Won Lee holds a patent for an RTX toxin production inhibitor and composition for treating symptoms of vibrio infection. This patent describes a method that utilizes an RTX toxin production inhibitor comprising N-(4-oxo-4H-thieno[3,4-c]chromen-3-yl)-3-phenylprop-2-ynamide and its derivatives. This method aims to repress the pathogenicity of vibrio bacteria without directly killing them, thus addressing the growing issue of antibiotic resistance.
Career Highlights
Zee-Won Lee is affiliated with Seoul National University, where he conducts research and develops innovative solutions for medical challenges. His work is recognized for its potential to revolutionize treatment methods for bacterial infections.
Collaborations
He collaborates with notable colleagues, including Sang Ho Choi and Lak Shin Jeong, to advance research in this critical area of health.
Conclusion
Zee-Won Lee's contributions to the field of vibrio infection treatment highlight the importance of innovation in addressing antibiotic resistance. His work represents a significant step forward in medical research and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile